UPFRONT

Leever Pursues MacDermid
DENVER—Specialty chemical manufacturer MacDermid has received an offer from Daniel Leever, its chairman and CEO, to acquire all of the company’s outstanding stock at $32.50 per share. Leever’s acquisition group includes Court Square Capital Partners and Joseph Silvestri, a MacDermid director and partner with Court Square. MacDermid’s board of directors has formed a special committee of its outside directors to consider the proposal.